Risk of ovarian cancer and the NF-{kappa}B pathway: genetic association with IL1A and TNFSF10

Bridget Charbonneau, Matthew S Block, William R Bamlet, Robert A Vierkant, Kimberly Kalli, Zachary C Fogarty, David N Rider, Thomas A Sellers, Shelley S Tworoger, Elizabeth M Poole, Harvey A Risch, Helga B Salvesen, Lambertus Kiemeney, Laura Baglietto, Graham Giles, Gianluca Severi, Britton Trabert, Nicolas Wentzensen, Georgia Chenevix-Trench, Alice S WhittemoreWeiva Sieh, Jenny Chang-Claude, Elisa Bandera, Irene Orlow, Kathryn L Terry, Marc T Goodman, Pamela J Thompson, Linda Cook, Mary Anne Rossing, Roberta B Ness, Steven A Narod, Jolanta Kupryjanczyk, Karen Lu, Ralf Butzow, Thilo Dork, Tanja Pejovic, Ian G Campbell, Nhu Le, Clareann H Bunker, Natalia Bogdanova, Ingo B Runnebaum, Diana M Eccles, James Paul, Anna H Wu, Simon A Gayther, Estrid Hogdall, Florian Heitz, Stanley B Kaye, Beth Karlan, Hoda Anton-Culver, Jacek Gronwald, Claus Hogdall, Diether Lambrechts, Peter Fasching, Usha N Menon, Joellen M Schildkraut, Celeste L Pearce, Douglas Levine, Susanne Kruger Kjaer, Daniel Cramer, James Flanagan, Catherine M Phelan, Robert Brown, Leon F A G Massuger, Honglin Song, Jennifer Doherty, Camilla Krakstad, Dong Liang, Kunle Odunsi, Andrew Berchuck, Allan Jensen, Jan Lubinski, Heli Nevanlinna, Yukie Tarumi Bean, Galina Lurie, Argyrios Ziogas, Christine S Walsh, Evelyn Despierre, Louise Brinton, Alexander Hein, Anja Rudolph, Agnieszka Dansonka-Mieszkowska, Sara H Olson, Philipp Harter, Jonathan Tyrer, Allison F Vitonis, Angela Brooks-Wilson, Katja K Aben, Malcolm C Pike, Susan J Ramus, Elisabeth Wik, Cezary Cybulski, Jie Lin, Lara E Sucheston, Robert Edwards, Valerie McGuire, Jenny Lester, Andreas Du Bois, Lene Lundvall, Shan Wang-Gohrke, Lukasz Szafron, Sandrina Lambrechts, Hannah P Yang, Matthias Beckmann, Liisa M Pelttari, Anne M Van Altena, David Van Den Berg, Mari Halle, Aleksandra Gentry-Maharaj, Ira Schwaab, Urmila Chandran, Janusz Menkiszak, Arif B Ekici, Lynne Wilkens, Arto Leminen, Francesmary Modugno, Grace Friel, Joseph H Rothstein, Ignace Vergote, Montserrat Garcia-Closas, Michelle A T Hildebrandt, Piotr Sobiczewski, Linda Kelemen, Paul D Pharoah, Kirsten B Moysich, Keith L Knutson, Julie Cunningham, Brooke Fridley, Ellen L Goode

Research output: Contribution to journalArticleResearchpeer-review

44 Citations (Scopus)

Abstract

A missense single-nucleotide polymorphism (SNP) in the immune modulatory gene IL1A has been associated with ovarian cancer risk (rs17561). Although the exact mechanism through which this SNP alters risk of ovarian cancer is not clearly understood, rs17561 has also been associated with risk of endometriosis, an epidemiologic risk factor for ovarian cancer. Interleukin-1a (IL1A) is both regulated by and able to activate NF-kB, a transcription factor family that induces transcription of many proinflammatory genes and may be an important mediator in carcinogenesis. We therefore tagged SNPs in more than 200 genes in the NF-kB pathway for a total of 2,282 SNPs (including rs17561) for genotype analysis of 15,604 cases of ovarian cancer in patients of European descent, including 6,179 of high-grade serous (HGS), 2,100 endometrioid, 1,591 mucinous, 1,034 clear cell, and 1,016 low-grade serous, including 23,235 control cases spanning 40 studies in the Ovarian Cancer Association Consortium. In this large population, we confirmed the association between rs17561 and clear cell ovarian cancer [OR, 0.84; 95 confidence interval (CI), 0.76-0.93; P <0.00075], which remained intact even after excluding participants in the prior study (OR, 0.85; 95 CI, 0.75-0.95; P <0.006). Considering a multiple-testing-corrected significance threshold of P <2.5 ? 10-5, only one other variant, the TNFSF10 SNP rs6785617, was associated significantly with a risk of ovarian cancer (low malignant potential tumors OR, 0.85; 95 CI, 0.79-0.91; P <0.00002). Our results extend the evidence that borderline tumors may have a distinct genetic etiology. Further investigation of how these SNPs might modify ovarian cancer associations with other inflammation-related risk factors is warranted.
Original languageEnglish
Pages (from-to)852 - 861
Number of pages10
JournalCancer Research
Volume74
Issue number3
DOIs
Publication statusPublished - 2014

Cite this